Skip to content
Search

Latest Stories

Transform your pharmacy into a specialist vaccinations hub

Travel Health and Immunisation was one of the fastest-growing businesses in the health sector until the pandemic hit in 2019/2020. For a successfully operating pharmacy travel clinic, the average takings for Travel Health and Immunisations were between £1,000 and £3,000 per week.

As the demand diminished during the pandemic, other immunisations emerged, such as Occupational Health Vaccinations and Childhood Immunisations. At more specialist pharmacies, we operated BCG Vaccinations and Mantoux Test services.


001 Alex LEUNG PROFILE PHOTO

Now, the engine of global travel has been restarted. However, around 80 per cent of GP surgeries have stopped offering a Travel Vaccination service at the Primary Care level.

This means there has never been a better time to plan and begin offering a Travel Vaccination service at your pharmacy.  A Travel Health service is not just for vaccinations and antimalarials, even though this is what the majority of pharmacy owners have been focusing on.

From a purely business standpoint, vaccinations and antimalarials bring in a substantial revenue; however, the true picture is much broader.

Yellow fever centre

One example I always love to share is the importance of setting up a Yellow Fever Centre

within a community pharmacy travel clinic. Most pharmacists just beginning their Travel Health service prefer a ‘wait and see’ approach, since Yellow Fever vaccinations are regulated by National Travel Health Network and Centre (NaTHNaC) and only their approved centres can provide this vaccination and are authorised to issue a certificate.

To open a Yellow Fever centre, the pharmacy would need to register with NaTHNac via the Yellow Fever Zone online system.

The pharmacist is also required to register with the NaTHNac Training Portal. All pharmacists who provide a Yellow Fever vaccination service must complete NaTHNac training every two years, based on their clinical governance. There is a cost incurred for both processes.

The cost of a Yellow Fever vaccine (Stamaril) is about £39. Most pharmacy travel clinics charge between £59 and £69 per vaccine; therefore, the profit per dose is £20-£30.

Some beginner travel clinics believe the registration process is too much trouble to go through to earn this profit, but this is a strategic mistake.

I have been a Responsible Supervising Clinician (RSC) at more than one hundred pharmacy-based Yellow Fever Centres in the UK. Experience has taught me that for each patient coming in for a Yellow Fever vaccination, an antimalarial tablet, Hepatitis A, Typhoid, Tetanus vaccinations (since most GPs has stopped their travel clinic) are requested, along with other travel health products such as mosquito repellents and anti sickness tablets.

Patients come in for a Yellow Fever vaccination, but walk out with all of these associated products, sometimes resulting in a profit of £300-£400 per person. If patients come as a couple or with their families, this profit can be multiplied by as much as a factor of six.

The Yellow Fever vaccination service is just one of the many Travel Health services that has a huge business potential providing you plan your business strategy correctly.

Clinical implications

A Yellow Fever vaccination does carry a risk if the patient is within certain at-risk groups, such as the over-60s. Typically, a risk and benefit evaluation is carried out, and both sides of the argument should be presented to the patient, enabling them to make their own informed decision whether to vaccinate or not.

Some countries in Africa and South America require a Yellow Fever certificate before the patient is allowed to enter the country. Most patients feel they would need to vaccinate to obtain the mandatory Yellow Fever certificate, but what most pharmacists fail to present is the alternative, i.e., an exemption certificate. As a Yellow Fever Centre, we have the power to issue exemption certificates on medical grounds.

As an experienced Travel Health practitioner, it is my job to ensure both sides of the arguments are presented to enable the patient to make an informed decision.

This is what makes being a specialist in Travel Medicine interesting and fun!

Occupational health vaccines

There has been a rapid growth in the demand for Occupational Health vaccination services in the UK. There are a number of professions that require certain vaccinations (including Tetanus, MMR, Hepatitis B, BCG, Varicella (Chickenpox or Shingles) and Influenza) before roles can be commenced.

Pharmacists should be equipped with the necessary skills and, more importantly, knowledge of the conditions, requirements and follow-ups of certain professions who require specific vaccinations.

Planned correctly, Occupational Health vaccination services could grow to become bigger than Travel Health services. There are three specialist pharmacists in the UK providing BCG vaccination services, but there is only one teaching this subject! It is time for you to receive specialist training in Occupational Health vaccinations within a community pharmacy.

Childhood immunisations

I personally trained a small number of community pharmacies in Childhood Immunisations which have started to provide Childhood Immunisations privately and which have achieved a good level of business.

A specialist vaccinations service, with expert support from your training provider, along with the vision and strategy to support your community pharmacy to upskill and upgrade your pharmacy into a specialist vaccinations hub, is possible, enabling you to pivot from being a Covid vaccinations centre into a complete, specialist vaccination service within community pharmacy. All our instructors are frontline clinicians who practice what we preach.

Next Steps

This is the most exciting time to begin offering a complete immunisation service.

You should:

1. Complete or renew your training in all immunisation services, including Travel Medicine, Occupational Health and Childhood Immunisations, with a specialist training provider.

2. Set up your Yellow Fever Centre in your pharmacy ASAP. Voyager Medical can support your application with our technical support team taking you through the process step-by-step.

3. Plan and execute your Specialist Vaccinations Service with expert training provider Voyager Medical, specialised in all areas of vaccination services.

The time is now. Start your Specialist Immunisations Service in your pharmacy today.

(Alex Leung is owner and clinical director of Voyager Medical, London regional adviser of Royal College of Physicians and Surgeons of Glasgow and chief pharmacist at Shell UK.)

More For You

Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Janet Morrison discusses pharmacy funding strategy at 2025 conference

Health Secretary Wes Streeting outlines government support for community pharmacy

CPE calls new funding deal a ‘reluctant yes’

Community Pharmacy England (CPE) was “reluctant” to accept the new pharmacy funding deal due to the significant funding gap, said the organisation’s chief executive Janet Morrison, while recognising the settlement as the first step towards stabilising the sector.

Addressing the 2025 Pharmacy Business Conference on Sunday at London Hilton Wembley, Janet shared insights into the behind-the-scenes work that led to the agreement.

Keep ReadingShow less
RPS transition to Royal College

RPS transition to Royal College: What it means for pharmacy

RPS transition to Royal College: What it means for pharmacy - Professor Claire Anderson explains

The Royal Pharmaceutical Society (RPS) is set to transition into a Royal College after securing majority support from its members in a recent ballot. However, concerns have been raised about the long-term implications of this shift.

With a voter turnout of 31.4%, 6,144 out of 19,594 eligible members participated in the vote on the Royal Charter changes. Of those, 71.1% supported the transition, well above the required two-thirds majority for a Special Resolution Vote.

Keep ReadingShow less
Pharmacies key to driving the shift from treatment to prevention

Bas Vorsteveld, Kenvue’s area managing director for Northern Europe.

Pharmacies can become frontline educators of self-care

Pharmacies have the potential to play a pivotal role in the government's transition from treatment-based healthcare to a more prevention-focused approach. However, for this shift to be successful, they require greater systemic support.

Bas Vorsteveld, Kenvue’s area managing director for Northern Europe, emphasises the importance of allowing pharmacists access to patient records to enable them to offer tailored advice and improve patient care.

Keep ReadingShow less
Community pharmacist consulting with a patient about independent prescribing.

Malcolm Harrison

Exclusive: National prescribing service 'critical' for community pharmacy, says Malcolm Harrison

A national prescribing service is “critical” for community pharmacy with all newly qualified pharmacists becoming independent prescribers from next year, according to Malcolm Harrison, chief executive of the Company Chemist Association (CCA).

“We are encouraging the NHS to work with community pharmacy to explore what that (prescribing service) could look like. There are pilots that are out there at the moment, and I know a number of pharmacies are engaged in those and exploring the different variations of what it could be,” Harrison told Pharmacy Business.

Keep ReadingShow less